子宮内圧カテーテルの世界市場-2023年～2030年

概要

世界の子宮内圧カテーテル市場は、そのダイナミクスに影響を与える様々な要因によって、長年にわたって著しい成長と変貌を遂げてきました。子宮収縮力を測定する子宮内圧カテーテル（IUPC）は、分娩時に羊膜嚢に挿入されます。

子宮内圧カテーテルは、カテーテル先端の圧力変換器を利用して羊膜腔の圧力を直接測定し、子宮収縮の力を定量的に測定します。収縮力はmmHg単位で測定され、関連ケーブルに接続された後、モニター上にグラフ表示されます。

特に新興経済諸国では、政府による斬新な製品の発売や研究開発により、先進的な液体充填カテーテルやTransducer-tipped Catheterの利用が引き続き促進され、世界の子宮内圧カテーテル市場を押し上げると思われます。それぞれの革新的な製品は、さまざまな年齢層の人々に利用される可能性があります。

市場促進要因：市場抑制要因

提携と拡大の拡大

新興経済諸国は、高額の投資、所得水準、インフラ整備を原動力として、ヘルスケア分野の改善において急速な成長を遂げています。いくつかの国では、妊娠数の増加により、子宮内圧カテーテルに対する大きな需要が発生しています。さまざまな国間での技術的進歩を伴うさまざまな提携、買収、製品の発売は、市場の成長を促進する重要な要因となるでしょう。

2021年12月17日、梨園経済開発公社（PEDC）と梨園市のリーダーシップにより、梨園のロウアーカービー地区がMillar, Inc.の新本社として発表されました。画期的な技術的進歩を救命医療の発明に変えるため、圧力センサー対応製品の開発・製造で定評のあるMillar, Inc.は、製造、ヘルスケア、テクノロジーの世界的権威と協力しています。

さらに2022年1月10日には、FDAの認可を受けたNuvo社の処方箋による遠隔妊娠モニタリングプラットフォームINVUが、非公開会社Nuvo Groupによって販売されています。Nuvoグループは、女性のみを対象とする国内最大かつ最も多様な医師診療管理会社であるユニファイド・ウィメンズ・ヘルスケアと提携しました。

さらに、新しい技術やさまざまなタイプの子宮内圧カテーテルの管理目的での利用が増加しています。妊娠におけるリスクの増加と革新的な管理製品開発のための研究の増加は、子宮内圧カテーテル市場の成長を促進する主な要因です。

子宮内圧カテーテルに関連する合併症

子宮内圧カテーテルの挿入は、分娩室で定期的に行われる一般的な手技であり、関連する問題は最小限に抑えられています。数多くの調査が、子宮内圧カテーテルの適用とそのまれな悪影響が、母体や新生児の罹患率に関連しています。

子宮内圧カテーテルの留置に関連して報告された珍しい結果は、子宮穿孔です。子宮内圧カテーテルは慎重に挿入されるべきであり、潜在的な影響を認識しておくことは、早期診断と最善の処置の選択に役立ちます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 高まる提携と拡大
    • 技術的進歩と開発の高まり
  • 抑制要因
    • 子宮内圧カテーテルに伴う合併症
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• SWOT分析
• 特許分析
• ロシア・ウクライナ戦争の影響分析
• DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

• 流体充填カテーテル
• トランスデューサ先端カテーテル

第8章 エンドユーザー別

• 病院
• 外来手術センター
• 老人医療

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第11章 企業プロファイル

• Cardinal Health
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Koninklijke Philips N.V.
• Utah Medical Products, Inc.
• CooperSurgical Inc.
• Laborie
• GE HealthCare
• Cook
• VYAIRE
• Millar, Inc.
• Clinical Innovations, LLC.

第12章 付録

Overview

The global intrauterine pressure catheters market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. An intrauterine pressure catheter (IUPC), which measures the force of uterine contractions, is put into the amniotic sac during labor.

Utilizing a pressure transducer at the catheter's tip, intrauterine pressure catheters measure the amniotic space's pressure directly, providing a quantitative measurement of the contraction's force. Contraction is measured in mm Hg and graphically shown on the monitor following connection to the relevant cable.

Government novel product launch and research, particularly in developing economies, will continue to drive utilization of advanced fluid-filled catheters or Transducer-tipped Catheters and boost the global intrauterine pressure catheters market. The respective innovative products are may be utilized in people with different age groups.

Market Dynamics: Drivers & Restraints

Growing collaborations and expansion

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for intrauterine pressure catheters owing to the rising pregnancies. Various collaborations, acquisitions and product launches with technological advancements among different countries will be a crucial factor driving the growth of the market.

On December 17, 2021, the Lower Kirby District of Pearland has been announced as the new headquarters for Millar, Inc., according to the leadership of the City of Pearland along with the Pearland Economic Development Corporation (PEDC). In order to transform ground-breaking technological advancements into life-saving medical inventions, Millar, Inc., an established developer and producer of pressure sensor-enabled products, collaborates with world authorities in manufacturing, healthcare, and technology.

Additionally on January 10, 2022, the FDA-cleared, remote pregnancy monitoring platform INVU which is prescription-initiated, by Nuvo is being marketed by Nuvo Group, a private company. Nuvo Group partnered with Unified Women's Healthcare, the largest, most diverse physician practice management company in the country that caters exclusively to women.

Furthermore, the rising utilization of novel technology and different types of intrauterine pressure catheters for the management purposes. Rising risks in pregnancies and increasing research for innovative management product development will be a major factor driving the growth of the intrauterine pressure catheters market.

Complications associated with intrauterine pressure catheters

Intrauterine pressure catheter insertion is a common technique carried regularly in labor and delivery units with minimal related problems. Numerous investigations have linked the application of intrauterine pressure catheters and its uncommon negative effects to maternal and newborn morbidity.

A uncommon reported consequence linked to the implantation of intrauterine pressure catheters is uterine perforation. Intrauterine pressure catheters should be inserted with care, and being aware of any potential consequences will help with an early diagnosis and the selection of the best course of action.

Segment Analysis

The global intrauterine pressure catheters market is segmented based on product type, end user and region.

Transducer-tipped Catheter segment accounted for approximately 73% of market share

A catheter tip pressure transducer is utilized for sensing the pressure in various sections of a living organism correctly and securely which comprises a pressure sensor positioned within the tip portion of a catheter. A pressure-sensitive diaphragm on which strain gauges are produced using the diffusion process is part of the pressure sensor.

The pressure sensor is attached but not firmly fastened to an insulated supporting element. Without being impacted by the thermal stresses that occur in the supporting element, the pressure sensor properly measures pressure. The uterine cavity is the intended location for this device. Many of the drawbacks of the conventional approach are eliminated with such a system.

According to the Journal of Reproductive Medicine publication, 2021, as safe as or safer than IUPCs already in use, Koala is just as functionally effective as or more so than IUPCs. The Koala also showed a number of benefits, such as a softer, shorter catheter tip that makes it easier to insert, a simpler, more compact design that makes it safer to insert and easier to operate, and precise transmission of signals to monitor.

Geographical Penetration

North America accounted for around 38% of market share in 2022

Due to the rising need for intrauterine pressure catheters in healthcare, manufacturers in North America have chances of increasing their operations. Increasing expenditure on healthcare and rising research studies, advancement of technologies and different types of products, and increase in biopharmaceutical or medical device business establishment across the region are also contributing to the growth of intrauterine pressure catheters market share of this region.

The market in this area is growing as people become more aware of various novel innovative products such as fluid-filled catheters. The aforementioned elements attest to North America's hegemonic position in the world. An intrauterine pressure catheter is used to monitor 15-20% (600,000-800,000) of the 4 million deliveries that take place each year in the United States. This method gives the practitioner diagnostic data that is helpful for determining the pressures produced by the myometrium and monitoring the health of the fetus throughout labor and delivery.

North America continues to be a key player in the global intrauterine pressure catheters market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for intrauterine pressure catheters in the U.S. United States have been proactive in executing several initiatives or researches, stimulating intrauterine pressure catheters demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global intrauterine pressure catheters market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all over the world were disturbed by the pandemic's broad lockdowns and strict limitations that started in early 2020.

Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for intrauterine pressure catheters. Now several research studies have been initiated and companies have again started launching novel products with high efficiency. Overall, the impact of the pandemic on the global intrauterine pressure catheters market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for innovative products, like transducer-tipped catheter.

Key Developments

• On March 22, 2023, in order to create a more inclusive pregnancy care encounter from the prenatal stage through delivery and labor, Royal Philips, an international pioneer in health technological devices, and Nuvo Group, a privately held corporation marketing INVU by Nuvo, a prescription-initiated, FDA-cleared, remote pregnancy tracking platform, have joined forces. Philips and Nuvo will work together to facilitate remote fetal monitoring pilot initiatives that increase access to and adherence to recommended care in outlying locations. The first program will be in a rural Colorado community.
• On August 16, 2022, the Australian Therapeutic Goods Administration (TGA) has given the Mikro-Cath Pressure Catheter manufacturer Millar, Inc. clearance to market it. The Mikro-Cath is a single-use pressure catheter designed for use in diagnostic and research procedures in medicine. For monitoring intra-compartmental, cardiovascular pressures and airway in people, the catheter is advised. The catheter is utilized as a short-term, restricted body contact minimally invasive device.

Competitive Landscape

The major global players in the market include: Cardinal Health, Koninklijke Philips N.V., Utah Medical Products, Inc., CooperSurgical Inc., Laborie, GE HealthCare, Cook, VYAIRE, Millar, Inc. and Clinical Innovations, LLC among others.

Why Purchase the Report?

• To visualize the global intrauterine pressure catheters market segmentation based on product type, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of intrauterine pressure catheters market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global intrauterine pressure catheters market report would provide approximately 53 tables, 46 figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by End User
• 3.3. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing collaborations and expansion
    • 4.1.1.2. Rising technological advancements and developments
  • 4.1.2. Restraints
    • 4.1.2.1. Complications associated with intrauterine pressure catheters
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. SWOT Analysis
• 5.6. Patent Analysis
• 5.7. Russia-Ukraine War Impact Analysis
• 5.8. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Fluid-filled Catheters*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Transducer-tipped Catheter

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ambulatory Surgical Centers
• 8.4. Geriatric

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. UK
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Cardinal Health*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Koninklijke Philips N.V.
• 11.3. Utah Medical Products, Inc.
• 11.4. CooperSurgical Inc.
• 11.5. Laborie
• 11.6. GE HealthCare
• 11.7. Cook
• 11.8. VYAIRE
• 11.9. Millar, Inc.
• 11.10. Clinical Innovations, LLC.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us